FIELD: pharmaceutics.
SUBSTANCE: invention relates to compound of formula (4) and industrially useful process for preparation of pharmaceutically valuable 4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile (1) and intermediate (4) to obtain this compound. Process for preparing compound is represented by the following reaction scheme: 
.
EFFECT: industrially useful process for preparation of pharmaceutically valuable 4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile.
4 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE POLYMORPHYL OF 4-[5-(PYRIDINE-4-YL)-1H-1,2,4-TRIAZOL-3-YL]-PYRIDINE-2-CARBONITRILE AND METHOD OF ITS OBTAINING | 2013 |
|
RU2639149C2 |
| 1,2,4-TRIAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND INTERMEDIATE COMPOUNDS | 1992 |
|
RU2095358C1 |
| 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
| NOVEL 1,2,4-TRIAZOLE COMPOUNDS, METHODS FOR THEIR PREPARING AND MEDICAMENTS CONTAINING THEREOF | 2002 |
|
RU2293733C2 |
| PYRIMIDIN-4-YL DERIVATIVES | 2010 |
|
RU2547098C2 |
| TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING | 1996 |
|
RU2161158C2 |
| SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS | 2014 |
|
RU2802185C2 |
| CONDENSED HETEROCYCLIC NITROGEN COMPOUNDS AND USING THEM AS INHIBITORS OF AMYLOID BETA PRODUCTION | 2010 |
|
RU2515976C2 |
| PYRIDIN-2-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2009 |
|
RU2494099C2 |
| HETEROCYCLIC COMPOUND | 2019 |
|
RU2808435C2 |
